Priapus Shot® Research
Supporting Research for the Priapusshot
- Peyronie’s Disease. This text gives an excellent review of the various treatments for Peyronie’s disease. It was written 5 years after the Priapus Shot® procedure was invented. Page 164 refers to the Priapus Shot® procedure.
- With surgery, “recurrence and ED rates[s] are high and some patients may experience permanent loss of sensation.” “…not acceptable to many patients because of the ‘loss’ of penile length.”
- Combination therapy works better than one therapy alone (there can be a synergy).
- Pump therapy corrected 51% of men-– satisfied with pump therapy alone (10 minutes twice a day). They did no other therapy in combination with the pump. Side effect was an increase in length.
- CoQ10 in double-blind study.
- Vitamin E. 1,200 IU daily.
- Platelet rich plasma for fibrosis and scar treatment.
- Platelet rich plasma for autoimmune.
- Platelet rich plasma for lichen sclerosus.
- PRP for Peyronie’s Disease
- Correct Testosterone deficiency to help Peyronie’s.
- Walking associated with decreased inflammation and improved erection. For full benefit, it’s best if the man works up to 21-25 miles per week.
- or in combination.
- Safety Information about Xiaflex (collagenase).
Notice that the rate of ED is 0.4% in placebo and 1.8% in the Xiaflex group
–> So, the implied incidence of ED from Xiafex would be 1.8 – 0.4 = 1.4% Also, note that the rate of known rupture from Xiaflex is 0.5%. The rate of possible rupture (heard a popping sound or extensive bruising, etc.) was 0.9%.
0.5 + 0.9 = 1.4% (click here to see the warning box). So, both of those stats support a rate of rupture/ED secondary to Xiaflex would be around 1.4% or 1 in 70.